|
|
|
|
|
|
|
||
has been cited by the following articles in journals that are participating in CrossRef's forward linking service: | ||
 |  | Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation Francesca Properzi, Rachel Lin, Jessica Kwok, Murali Naidu, Toin H. van Kuppevelt, Gerdy B. ten Dam, Luiz M. Camargo, Ruma Raha-Chowdhury, Yoko Furukawa, and Tadahisa Mikami European Journal of Neuroscience (2008) 27: 593 Link to Article |
| ||
| ||
| ||
| | Emerging and potential therapies for Alzheimer's disease Heledd H Griffiths, Isobel J Morten, and Nigel M Hooper Expert Opinion on Therapeutic Targets (2008) 12: 693 Link to Article |
| ||
| ||
| ||
| | Regulation of proBACE1 by Glycosaminoglycans David H. Small, David W. Klaver, and Marie Beckman Neurodegenerative Diseases (2008) 5: 206 Link to Article |
| ||
| ||
| ||
| | Engineered Heparins: Novel β-Secretase Inhibitors as Potential Alzheimer’s Disease Therapeutics S.J. Patey, E.A. Edwards, E.A. Yates, and J.E. Turnbull Neurodegenerative Diseases (2008) 5: 197 Link to Article |
| ||
| ||
| ||
| | Engineered Bio-Active Polysaccharides from Heparin Scott E. Guimond, Jeremy E. Turnbull, and Edwin A. Yates Macromolecular Bioscience (2006) 6: 681 Link to Article |
| ||
| ||
| ||
| | Dialysis-Related Amyloidosis: Late Finding or Hidden Epidemic? Laura M. Dember and Bertrand L. Jaber Seminars in Dialysis (2006) 19: 105 Link to Article |
| ||
| ||
| ||
| | Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease Dirk Beher and Samuel L Graham Expert Opinion on Investigational Drugs (2005) 14: 1385 Link to Article |
| ||
| ||
| ||
| | Survey of the year 2003 commercial optical biosensor literature Rebecca L. Rich and David G. Myszka Journal of Molecular Recognition (2005) 18: 1 Link to Article |
| ||
| ||
| ||
| | Emerging treatment approaches for the systemic amyloidoses Laura M. Dember Kidney International (2005) 68: 1377 Link to Article |
| ||
| ||
| ||
| | Future directions in the treatment of Alzheimer’s disease Roger Bullock Expert Opinion on Investigational Drugs (2004) 13: 303 Link to Article |
| ||
| ||
| ||
| | Glycomics: a pathway to a class of new and improved therapeutics Zachary Shriver, S. Raguram, and Ram Sasisekharan Nature Reviews Drug Discovery (2004) 3: 863 Link to Article |
| ||
| ||
| ||
| | BACE1 and Presenilin: Two Unusual Aspartyl Proteases Involved in Alzheimer’s Disease Diana-Ines Dominguez, Dieter Hartmann, and Bart De Strooper Neurodegenerative Diseases (2004) 1: 168 Link to Article |
| ||
| ||
| ||
| | Controlling the BACEs Suzanne Farley Nature Reviews Neuroscience (2003) 4: 936 Link to Article |
| ||
| ||
| ||
|
|